Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome

Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome

(2014) E. Diamanti-Kandarakis et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention

(2014) L. J. Moran et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Clinical Significance of Inflammatory Markers in Polycystic Ovary Syndrome: Their Relationship to Insulin Resistance and Body Mass Index

(2013) Nervana Samy et al.   DISEASE MARKERS

Serum Levels of Leptin and Homocysteine in Women with Polycystic Ovary Syndrome and Its Relationship to Endocrine, Clinical and Metabolic Parameters

(2013) A Atamer et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

(2011) Mark O. Goodarzi et al.   Nature Reviews Endocrinology

Serum High-Sensitivity C-Reactive Protein and Homocysteine Changes During Hormonal Therapy in Women With Polycystic Ovary Syndrome: A Prospective, Matched Study

(2010) Anastasios Makedos et al.   ANGIOLOGY

Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine

(2010) AhmedM Mohamadin et al.   ANNALS OF SAUDI MEDICINE

Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: Comparison with C-reactive protein

(2010) Hidenori Nishida et al.   CYTOKINE

Serum Soluble Glycoprotein 130 Concentration Is Inversely Related to Insulin Sensitivity in Women With Polycystic Ovary Syndrome

(2010) A. Nikolajuk et al.   DIABETES

Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus

(2010) Maike Anderssohn et al.   Diabetes & Vascular Disease Research

Comparison Of The Effects Of Atorvastatin And Simvastatin In Women With Polycystic Ovary Syndrome: A Prospective, Randomized Study

(2010) C. Kaya et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome

(2010) Henri Sova et al.   FERTILITY AND STERILITY

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis

(2010) Héctor F. Escobar-Morreale et al.   FERTILITY AND STERILITY

Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome

(2010) Åsa Lindholm et al.   GYNECOLOGICAL ENDOCRINOLOGY

The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome

(2010) Agnieszka Lenarcik et al.   GYNECOLOGICAL ENDOCRINOLOGY

Obesity-Related Lipid Profile and Altered Insulin Incretion in Adolescents With Polycystic Ovary Syndrome

(2010) Annamaria Fulghesu et al.   JOURNAL OF ADOLESCENT HEALTH

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

(2010) Robert A. Wild et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Vascular Risk in Young Women With Polycystic Ovary and Polycystic Ovary Syndrome

(2010) Cesare Battaglia et al.   OBSTETRICS AND GYNECOLOGY

High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome

(2009) Fatma Ferda Verit   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome

(2009) RL Thomson et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Metformin decreases angiogenesis via NF-κB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1

(2009) Bee K. Tan et al.   CARDIOVASCULAR RESEARCH

Body Iron Stores and Glucose Intolerance in Premenopausal Women: Role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism

(2009) M. A. Martinez-Garcia et al.   DIABETES CARE

Effects of Metformin With or Without Supplementation With Folate on Homocysteine Levels and Vascular Endothelium of Women With Polycystic Ovary Syndrome

(2009) S. Palomba et al.   DIABETES CARE

Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking

(2009) Manuel Luque-Ramírez et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome

(2009) Evanthia Diamanti-Kandarakis et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome

(2009) Flavia Tosi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors

(2009) Cemil Kaya et al.   FERTILITY AND STERILITY

Relationship between interleukin-6 levels and ambulatory blood pressure in women with polycystic ovary syndrome

(2009) Cemil Kaya et al.   FERTILITY AND STERILITY

The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome

(2009) Yilmaz Nafiye et al.   FERTILITY AND STERILITY

C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome

(2009) Cemil Kaya et al.   FERTILITY AND STERILITY

Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome

(2009) Athina Markou et al.   FERTILITY AND STERILITY

Review of cardiovascular risk factors in women

(2009) Odette Evangelista et al.   Gender Medicine

Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome

(2009) Baha Oral et al.   GYNECOLOGICAL ENDOCRINOLOGY

Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance

(2009) Ramazan Gen et al.   GYNECOLOGICAL ENDOCRINOLOGY

Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome

(2009) Şenay Arikan et al.   GYNECOLOGICAL ENDOCRINOLOGY

Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype

(2009) M. Rizzo et al.   HUMAN REPRODUCTION

Apnea-hypopnea index in nonobese women with polycystic ovary syndrome

(2009) Hsiao-Ping Yang et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

The relationship of the interleukin-6 −174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients

(2009) M. Erdogan et al.   International Journal of Immunogenetics

Mitochondrial Complex I Impairment in Leukocytes from Polycystic Ovary Syndrome Patients with Insulin Resistance

(2009) Victor M. Victor et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis

(2009) Linda L. Humphrey et al.   MAYO CLINIC PROCEEDINGS

Study on Chronic Low-Grade Inflammation and Influential Factors of Polycystic Ovary Syndrome

(2009) Xiangyan Ruan et al.   MEDICAL PRINCIPLES AND PRACTICE

Evidence of proatherogenic inflammation in polycystic ovary syndrome

(2009) Frank González et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Role of Haptoglobin in Polycystic Ovary Syndrome (PCOS), Obesity and Disorders of Glucose Tolerance in Premenopausal Women

(2009) Francisco Álvarez-Blasco et al.   PLoS One

Disturbed stress responses in women with polycystic ovary syndrome

(2009) S. Benson et al.   PSYCHONEUROENDOCRINOLOGY

Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells

(2009) Qiuju Chen et al.   Reproductive Biology and Endocrinology

Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS

(2009) Cemil Kaya et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF

(2009) Paolo Giovanni Artini et al.   Human Fertility

Serum C-Reactive Protein Levels in Normal-Weight Polycystic Ovary Syndrome

(2009) Ji Young Oh et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome

(2008) Levent Kebapcilar et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS)

(2008) Taner Ozgurtas et al.   ATHEROSCLEROSIS

Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects

(2008) Sharmalar Rajendran et al.   ATHEROSCLEROSIS

Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)

(2008) Evanthia Diamanti-Kandarakis et al.   CLINICAL ENDOCRINOLOGY

Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?

(2008) Gustavo Mafaldo Soares et al.   CLINICAL ENDOCRINOLOGY

A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome

(2008) Lisa J. Moran et al.   CLINICAL SCIENCE

Insulin Resistance Is Associated With Decreased Circulating Mannan-Binding Lectin Concentrations in Women With Polycystic Ovary Syndrome

(2008) I. Kowalska et al.   DIABETES CARE

Low-grade chronic inflammation is not accompanied by structural arterial injury in polycystic ovary syndrome

(2008) Laura Olinda Bregieiro Fernandes Costa et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?

(2008) Evanthia Diamanti-Kandarakis et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Plasma homocysteine concentrations and the single nucleotide polymorphisms in the methionine synthase gene (MTR 2756A>G): Associations with the polycystic ovary syndrome

(2008) M. Palep-Singh et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Thrombin-Activatable Fibrinolysis Inhibitor and Cardiovascular Risk Factors in Polycystic Ovary Syndrome

(2008) M. Erdoğan et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Oxidative Stress Markers in Young Patients with Polycystic Ovary Syndrome, The Relationship between Insulin Resistances

(2008) M. Karadeniz et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Increased Low Grade Inflammatory Serum Markers in Patients with Polycystic Ovary Syndrome (PCOS) and their Relationship to PPARγ Gene Variants

(2008) B. Knebel et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease

(2008) Mesut Oktem et al.   FERTILITY AND STERILITY

Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study

(2008) Fulvia Mancini et al.   FERTILITY AND STERILITY

Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome

(2008) Yuwen Wu et al.   FERTILITY AND STERILITY

Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome

(2008) Cemil Kaya et al.   FERTILITY AND STERILITY

Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis

(2008) Konstantinos A. Toulis et al.   FERTILITY AND STERILITY

Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study

(2008) Cemil Kaya et al.   FERTILITY AND STERILITY

The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function

(2008) Senay Arikan et al.   FERTILITY AND STERILITY

Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters

(2008) Baris Onder Pamuk et al.   FERTILITY AND STERILITY

Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome

(2008) Feridun Karakurt et al.   GYNECOLOGICAL ENDOCRINOLOGY

Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment

(2008) Joanna Jakubowska et al.   GYNECOLOGICAL ENDOCRINOLOGY

Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome

(2008) Robert Thomann et al.   GYNECOLOGICAL ENDOCRINOLOGY

Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome

(2008) K. Berneis et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey

(2008) Sevki Cetinkalp et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome

(2008) Nafiye Yilmaz et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome

(2007) Christina Charitidou et al.   ATHEROSCLEROSIS

Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome

(2007) S. Benson et al.   BRAIN BEHAVIOR AND IMMUNITY

Asymmetrical Dimethylarginine, Inflammatory and Metabolic Parameters in Women with Polycystic Ovary Syndrome before and after Metformin Treatment

(2007) Dennis Heutling et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM